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. ERPs established by stakeholder panels, and whose members are thoroughly vetted by the Offi cial Methods Board (OMB), evaluate methods against standard method performance requirements (SMPRs) developed by stakeholder bodies. A method approved First Action will remain First Action for a period of 2 years. During this time, the method will be used in laboratories, and method users will be asked to provide feedback. An ERP will monitor the performance of the method, and after the 2-year period, the ERP will determine whether the method should be recommended to the OMB for Final Action.
Standard Method Performance Requirements
SMPRs, based on the fi tness-for-purpose statement developed by stakeholders, establish the minimum performance that stakeholders expect of a method. SMPRs provide detailed information about analytical requirements for a test method.
SMPRs are developed through voluntary stakeholder consensus by those who use and need methods, and refl ect the analytical requirements of the user community, taking into account technological considerations, compliance expectations, and other issues deemed priority by stakeholders and examined carefully by topic-specifi c working groups who are experts in the fi eld. The process by which SMPRs are developed ensures transparency, openness, balance of interest, due process, appeals, and voluntary consensus. In developing SMPRs, AOAC typically forms smaller working groups from a larger stakeholder body to address specifi c analytical issues. Working groups provide technical expertise in establishing SMPRs, which set the criteria that methods must meet. After working groups reach agreement, recommendations such as SMPRs (for example, sensitivity, specifi city, analytical range, and LOD) are provided to the stakeholder panel for approval.
Once SMPRs are adopted by stakeholders, candidate methods (which are received through calls for methods and literature searches) are reviewed by ERPs to determine if they meet the performance requirements specifi ed in the SMPR. It is possible that several methods of analysis could potentially meet the requirements of an SMPR, and be approved by an ERP. Multiple methods would provide analysts with more freedom to select and use a method that best fi ts their laboratory. The SMPR approach is less prescriptive than the traditional Offi cial Methods SM program and more similar to the Codex criteria-based approach, which involves compliance with a set of criteria without endorsement of specifi c methods. However, the new AOAC system does allow for the designation of "dispute resolution" methods where it is necessary to specify a single "reference" method. Dispute resolution methods are identifi ed as such in the applicability statement of the method.
Infant Formula Initiative
On April 26, 2010, AOAC reached an agreement with the International Formula Council (IFC) on a 2-year project to create SMPRs for methods for infant and adult nutritionals nutrients: vitamin A, vitamin D, vitamin B 12 , folate, inositol, vitamin E, nucleotides, ultra trace minerals (selenium, chromium, molybdenum), carnitine, iodine, and pantothenic acid (vitamin B 5 ). Methods are urgently needed for dispute resolution because a variety of methods is used around the world for these products.
AOAC formed an advisory panel in the summer of 2010 to identify and prioritize the infant formula nutrients most needing SMPRs. The advisory panel decided to organize the nutrients into four groups of about fi ve nutrients for the sake of project management. The groups were organized to maximize complementary methods that might use similar procedures, and to represent different areas of expertise so that the work of subject matter experts in one specifi c area could be better managed over the 2-year contract.
The nutrient priorities and groupings were forwarded to the Stakeholder Panel on Infant Formula and Adult Nutritionals (SPIFAN), which was charged with organizing working groups. Methods for vitamins A and E were considered similar enough to organize into one logical unit. SPIFAN then organized individual working groups for vitamins B 12 and D, folate, and inositol. The fi ve working groups met at AOAC headquarters on November 8-12, 2010, to draft SMPRs for each of the nutrient methods groups. The resulting draft SMPRs were posted on the AOAC website in February 2011, for a public comment period. All comments received were carefully considered and reconciled. The fi nal draft SMPRs were reviewed and approved by SPIFAN on April 4-6, 2011 (Appendix 1).
At the same time the SMPRs were being drafted, the nutrientspecifi c working groups also evaluated a total of approximately 80 (narrowed down from about 150) of the most promising methods for further evaluation, and recommended potential candidate methods most likely to meet fi tness-for-purpose and the draft SMPRs for vitamins A, B 12 , and D, folate, and inositol. High-technology methods using LC-MS/MS were most often chosen. In early 2011, the method developers for each of the selected candidate methods were notifi ed and asked to prepare an informative presentation on their method for review by the stakeholder panel and the ERP. In cases where a method developer could not be identifi ed, an advocate for the method was recruited to prepare an informative presentation.
In April 2011, SPIFAN reviewed the presentations for the most promising methods that were selected by the working groups in order to assess their potential for further evaluation and possible adoption as First Action by an ERP.
After the SPIFAN review of the informative presentations, the candidate methods were transferred to the ERP for consideration. The ERP recruited a primary and a secondary reviewer for each candidate method to determine the worthiness and fi tness-for-purpose of each method, using the SMPR as the standard. The primary and secondary reviewers summarized the advantages and disadvantages of their assigned method, and its compliance to the SMPR. Candidate methods were then discussed thoroughly by the entire panel, stakeholders, and observers present. The methods were evaluated for completeness of validation and likelihood of meeting SMPRs (appropriateness for the intended use, clarity of the method description, ruggedness, reproducibility, recovery, analytical range, LOQ, etc.).
In April 2011, SPIFAN reached consensus on fi tness-forpurpose statements for nucleotides and ultra trace minerals, AOAC issued a call for methods, and working groups developed draft SMPRs, which were posted for public comment. Also in April, each working group chair provided background and examined analytical challenges, regulatory requirements, and existing methodology for nucleotides and ultra trace minerals in an effort to reach consensus on the expected performance of each candidate method.
During standards and samples are saponifi ed in a basic ethanol-water solution to convert fats to fatty acids, and retinol esters to retinol. Although already approved as AOAC Offi cial Method 2001.13, the ERP agreed that the method should be approved for infant formula and adult nutritionals as Offi cial Method 2011.15, and still undergo the same evaluation process as all other methods for this project. The ERP also recommended that additional information be collected for all types of infant formulas and adult nutritional matrixes at varied concentration levels, as indicated in the SMPRs, prior to adoption as a Final Action method.
Vitamin B 12
The Working Group on Vitamin The Working Group on Vitamin B 12 also recommended two methods that were similar enough to be considered together. Using HPLC After Purifi cation on an Immunoaffi nity Column," submitted by Central Laboratories Friedrichsdorf GmbH (CLF; a wholly owned subsidiary of the DANONE Group). Both methods are based on extraction, immunoaffi nity column cleanup, and LC/UV quantitation. The methods were adopted as Offi cial Methods 2011.08 and 2011.09, respectively, and the ERP recommended that they be combined into a single method for consideration of Final Action approval.
The working group also recommended "Determination of Vitamin B 12 by HPLC" submitted by Abbott Nutrition. This method uses SPE to concentrate sample extracts, size exclusion and reversed-phase chromatography to separate vitamin B 12 , and visible detection at 550 nm to measure vitamin B 12 concentrations. The ERP adopted the method as Offi cial Method 2011.10, and suggested that additional clarifi cation on standardization, calibrations, and precision would be helpful when the method is considered for Final Action status. The third method, "Simultaneous Determination of Vitamin D 2 and D 3 by LC-MS/MS for Infant Formula and Adult Nutritionals," submitted by Abbott Nutrition, uses an internal isotope standard that is saponifi ed with the test sample. Vitamin D is extracted using liquid-liquid extraction, and the sample is evaporated under nitrogen. The dried sample is then reconstituted, fi ltered, and analyzed by LC-MS/MS. The ERP adopted this method as Offi cial Method 2011.13.
Inositol
In November 2010, the Working Group on Inositol, chaired by Harvey Indyk, Fonterra Co-operative Group Ltd, and Karen Schimpf, Abbott Nutrition, recommended the development of (1) a hybrid GC method that combines two GC methods, and (2) a hybrid LC method that combines two LC methods. The hybrid GC method combines a method submitted by CLF, "Gas Chromatographic Determination of Inositol in Foodstuffs," and one submitted by Nestlé Research Center, "Inositol by Gas Chromatography." The fi rst GC method uses fl ame ionization detection (FID) to measure free myo-inositol and inositol. The second GC method uses a GC/FID with overnight hydrolysis (16 h) to determine bound inositol.
The proposed hybrid LC method combines "Ion Chromatographic Determination of Inositol in Infant Formulae and Clinical Products for Enteral Feeding" [Tagliaferri, E.G., Bonetti, G., & Blake, C.J. (2000) J. Chromatogr. A 879, 129-135] that uses ion exchange HPLC pulsed amperometric detection to measures total inositol, and "Determination of Myo-inositol in Nutritionals by HPLC Column Switching and Pulsed Amperometry," submitted by Abbott Nutrition, that measures only free inositol.
At the time, the ERP agreed that none of the individual methods met the requirements of the SMPR applicability statement for inositol. However, the ERP requested that the working group evaluate the methods separately (four individual methods vs two hybrid methods). The ERP also requested more information for the GC methods. The ERP did not vote on the candidate methods for inositol, and agreed to re-examine these methods at the AOAC Annual Meeting in September 2011, when additional information would be available.
Subsequently, in September 2011, an ERP approved Offi cial Method 2011.18 for determination of myo-inositol (free and bound as phosphatidylinositol) in infant formula and adult/pediatric nutritional formula. The HPLC method, submitted by Abbott Nutrition, has been in use since 1994. In addition, the ERP endorsed continuation of research for the method.
Nucleotides
The Working Group on Nucleotides, chaired by Brendon Gill, Fonterra Co-operative Group Ltd, recommended two methods for ERP review and possible approval. In " A Liquid Chromatographic Method for Routine Analysis of 5′-Mononucleotides in Pediatric Formula," submitted by Fonterra Co-operative Group Ltd, the sample is dissolved in a high-salt solution to inhibit protein and fat interactions. Nucleotides are then extracted using strong anion exchange SPE, and then are analyzed by reversed-phase LC using photodiode array detection. Quantitation is by internal standardization against thymidine 5′-monophosphate. Advantages of the method, approved as Offi cial Method 2011.20, are security of internal standard, moisture correction of calibration standards, and a simple mobile phase system.
In "Development and Application of an HILIC-MS/MS Method for the Quantitation of Nucleotides in Infant Formula," submitted by Kinjo Gakuin University [J. Agric. Food Chem. (2010) 58, 9918-9924] , and approved as Offi cial Method 2011.21, the sample is dissolved in water followed by centrifugal ultrafi ltration to remove compounds with a molecular weight higher than 3000. Isotopically labeled internal standards are used from the beginning of sample preparation, and a HILIC column is used for LC separation. Both milk-based and soybased infant formula matrixes were studied. The method is highly selective, sensitive, and accurate (stable isotope internal standards), with good precision. It is quick and uses a simple sample preparation step (centrifugal ultrafi ltration) for easy operation.
Both methods were approved by the ERP with recommendations to optimize the methods. For example, for the latter method, it was recommended to evaluate for robustness and optimizing chromatography to reduce the run time.
Ultra Trace Minerals
As recommended by the Working Group on Ultra Advantages of the method are as follows: time to result is less than 8 h in many samples, addition of an internal standard up front provides good precision data, use of the latest collision/ reaction cell technology for minimal interference, and better LOQ than required by the SMPRs. In addition, the method uses equipment/procedures common for major minerals (ICP-AES) and total iodine (ICP-MS). It has been implemented in routine use at Abbott Nutrition for about 1 year, without issues. The method uses a 2-step digestion process to maximize carbon removal.
In addition to First Action approval, the ERP recommended to examine optimizing the method from a 2-to 1-step digestion process and check for nickel in sample matrixes.
First to Final Action Recommendations
In addition to approving 15 First Action methods, the ERPs recommended collection of additional information to advance these First Action methods to Final Action status: evaluate methods against all of the types of infant formula identifi ed in the SMPRs; evaluate the precision and accuracy of methods using samples representing the different types of infant formula identifi ed in the SMPRs; properly characterize standards and clarify calibration procedures; demonstrate proof of performance (in terms of proprietary methods and chips) tested with either reference materials or by system suitability; demonstrate reproducibility if ERPs determine it to be necessary; test all future analyses on ready-to-feed (reconstituted) materials; and if possible, include information on rice-based infant formula.
Conclusions
Manuscripts were prepared from the available information, and submitted to the ERPs for review and publication for each of the 15 methods described above and approved as AOAC First Action Offi cial Methods, during the "Standards Development and International Harmonization: AOAC INTERNATIONAL MidYear Meeting" in June 2011, and the AOAC Annual Meeting in September 2011. The fi rst collection of seven manuscripts to be reviewed and approved through this peer-review process is published in this issue.
Under the SPIFAN project, the ERPs recommended that all First Action methods should undergo further study in a singlelaboratory validation (SLV) using centrally prepared testing materials. Once the SLVs are complete, data will be reviewed by ERPs in an effort to select one dispute resolution method per nutrient, which will also be published in subsequent issues of this journal.
Details are yet to be fi nalized at this writing, but dispute resolution methods most likely will undergo further study to generate additional information for consideration as Final Action status.
